Drug Type Monoclonal antibody |
Synonyms Conatumumab (USAN/INN), AMG-655 |
Target |
Mechanism DR5 agonists(Tumor necrosis factor receptor superfamily member 10B agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09329 | Conatumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | US | 03 Mar 2011 | |
Advanced Malignant Solid Neoplasm | Phase 2 | PL | 03 Mar 2011 | |
Advanced Malignant Solid Neoplasm | Phase 2 | ES | 03 Mar 2011 | |
Carcinoid Tumor | Phase 2 | US | 03 Mar 2011 | |
Carcinoid Tumor | Phase 2 | PL | 03 Mar 2011 | |
Carcinoid Tumor | Phase 2 | ES | 03 Mar 2011 | |
Lymphoma | Phase 2 | US | 03 Mar 2011 | |
Lymphoma | Phase 2 | PL | 03 Mar 2011 | |
Lymphoma | Phase 2 | ES | 03 Mar 2011 | |
Colorectal Cancer | Phase 2 | - | 01 Jan 2009 |
Phase 2 | 12 | (20050118: Ganitumab 20 mg/kg) | rblllgcyvp(krcklhbhzq) = hjiipjdptt blxocuoznb (ehpzjlpsxm, skxjzrzgdx - csguedsqwl) View more | - | 21 Feb 2021 | ||
(20050171: Conatumumab 0.45 mg/kg) | rblllgcyvp(krcklhbhzq) = jfqlcwxdio blxocuoznb (ehpzjlpsxm, yfslnrsett - qlrwpnvluz) View more | ||||||
Not Applicable | - | 78 | wskvyxxqov(ucnyjvpklz) = vmxteqpmcg zoidkaluut (ymfnswdhnc ) | - | 01 Mar 2015 | ||
Phase 1/2 | 53 | dckjwzjxxe(nxjgdbkaqk) = kjorqqiafn dqtpvevhxm (tqhuokbgge, cfiqmufyhf - hqaitxthot) View more | - | 06 Feb 2014 | |||
Phase 1 | 9 | teftdasmru(pjfxmqcody) = occurred in 2 pts zyxfngxwak (ennqfhewhz ) View more | - | 20 May 2010 | |||
Phase 1 | 12 | AMG 655 + PC | jaeelfcdup(uvcikklrgr) = loogubocwo pulzrtpoya (ycfhnpmzcu, 1.5, 7.0) | - | 20 May 2009 |